Articles from November 2024

Carver College of Medicine GAP Fund awards $108,800 to four faculty and staff teams
Wednesday, November 27, 2024
The Carver College of Medicine GAP Fund has awarded a total of $108,800 to four faculty and staff teams to advance the development of innovative medical devices and health software.
Three University of Iowa Startups Secure NIH SBIR Funding to Advance Medical Innovations
Wednesday, November 27, 2024
Halide Biologics, Zwicoat Materials Innovations, and Geminii Health have been awarded Small Business Innovation Research (SBIR) Phase I grants from the National Institutes of Health (NIH), totaling over $960,000.

UI researchers receive funding for clinical trials in new cancer treatment
Friday, November 22, 2024
Taking a page from culinary arts, the researchers are creating foam substances that make tumors more vulnerable to treatment.

Iowa Nurse Innovators Pitch Competition: Healthcare Innovation in Action
Thursday, November 21, 2024
The event provided a platform for nurse innovators to pitch their ideas for the chance to win up to $20,000 in funding to develop their solutions.

Building Iowa’s medical innovation ecosystem
Thursday, November 21, 2024
Leaders discuss opportunities for investment, development of health care innovation.

Targeting Tumors
Monday, November 4, 2024
Perspective Therapeutics’ pioneering treatment now in clinical trials